Published by Pinnacle Pulse, maker of a self-tracking app. We have no affiliate or sales relationship with any peptide seller. Editorial policy →
Semaglutide legal status in the EU, the US and in sport
By Pinnacle Pulse Editorial Team · Status as of 16 October 2026 · Next scheduled update: 14 January 2027
Short answer: Semaglutide is an authorized, prescription-only medicine in the EU and the US. Buying it without a prescription, or from sellers outside the licensed pharmacy system, is where the legal and safety problems start. Regulators on both sides of the Atlantic have warned about falsified and “research-only” products. WADA does not prohibit it but monitors its use. This is general information, not legal advice.
At a glance
| Where | Status on 16 October 2026 |
|---|---|
| EU | Centrally authorized medicines since 8 February 2018; prescription only |
| US | FDA-approved prescription drug; FDA proposed in May 2026 not to put it on the 503B bulks list; salt forms have no lawful basis in compounding |
| WADA | Not prohibited; in the 2027 Monitoring Program, in and out of competition |
European Union
Semaglutide has been on the EU market since 8 February 2018, when the first product got an EU-wide marketing authorization through the European Medicines Agency. Others followed, for type 2 diabetes, for weight management and for further uses since.
All of them are prescription-only. Powders and vials marketed as research chemicals aren’t the authorized medicine at all.
In practice, the bigger problem is fakes. In September 2025 EMA and the national agencies sounded the alarm about a sharp rise in illegal GLP-1 medicines in the EU, many pushed through social media ads and fake online pharmacies. Their tip was simple: look for the EU common logo, which legitimate online pharmacies have to show.
United States
FDA has approved several semaglutide products, all prescription-only.
Compounded copies are the messier topic. Large compounders, which the law calls outsourcing facilities, can work from bulk semaglutide only if it is on the 503B bulks list or if the drug is on FDA’s shortage list. On 1 May 2026 FDA proposed in the Federal Register to keep semaglutide, tirzepatide and liraglutide off that list. Its argument: a shortage or a backorder is not the “clinical need” the list is meant for, and shortages have their own legal route. When we checked FDA’s drug shortage database on 16 October 2026, semaglutide injection wasn’t listed; the only semaglutide entry was a tablet being discontinued.
FDA’s page on unapproved GLP-1 drugs is unusually specific. Salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients, and FDA says it knows of no lawful basis for compounding with them. It has sent warnings to companies selling semaglutide to consumers under labels like “for research purposes” or “not for human consumption”. It has also seen counterfeits. By 31 May 2026 it had 990 adverse-event reports for compounded semaglutide.
Sport
WADA does not prohibit semaglutide. It is on the 2027 Monitoring Program, in and out of competition, so labs record it and WADA can decide later. Publishing the 2027 list on 21 September 2026, WADA said GLP-1 receptor agonists keep their status while it gathers more data, and that it had started a second study. A change, if one comes, would normally arrive with a future annual list.
What the research does not show
The big trials behind semaglutide's approval used licensed products, with doctors involved. Falsified pens, salt forms and research-chemical powders are a different thing, and they are exactly what the warnings above are about. See [Semaglutide: what the research shows](/research/semaglutide).FAQ
Can I buy semaglutide without a prescription in the EU?
No. It is a prescription-only medicine. EMA has warned about a sharp rise in illegal GLP-1 medicines sold in the EU, and legitimate online pharmacies have to show the EU common logo.
Is compounded semaglutide legal in the US?
Only within narrow conditions. In May 2026 FDA proposed not to add semaglutide to the 503B bulks list, and it says salt forms have no lawful basis in compounding.
Is semaglutide banned in sport?
No. It is not prohibited, but it is part of WADA’s 2027 Monitoring Program, in and out of competition.
Sources
- EMA. Medicines data (download of centrally authorised medicines, checked 16 October 2026). ema.europa.eu
- EMA. Warning about sharp rise in illegal medicines sold in the EU (3 September 2025). ema.europa.eu
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. fda.gov
- Federal Register, 1 May 2026, FR Doc. 2026-08552 (docket FDA-2018-N-3240). govinfo.gov
- WADA. WADA publishes 2027 Prohibited List (21 September 2026). wada-ama.org
- USADA. Athlete advisory: what’s new on the 2027 WADA Prohibited List? usada.org
- FDA. Drug shortages database, checked 16 October 2026. accessdata.fda.gov
Facts last checked: 16 October 2026.
About this article
Written by: the Pinnacle Pulse Editorial Team, the people who make the Pinnacle Pulse app. We work only from primary sources such as regulators, legal texts, trial registries and PubMed, and we remove claims we can’t check against one.
This page has not been reviewed by a lawyer. It is general information, not legal advice.
Spotted an error? Our editorial policy explains how to report it and how we correct mistakes.
Change log
- 16 October 2026: First published.
From the makers of this site: Pinnacle Pulse is a neutral tracking app. We don’t sell or recommend any substance. About Pinnacle Pulse
This page is general information about the law as of the date shown. It is not legal advice. For your own situation, consult a lawyer.